Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells Jessika Bertacchini, Chiara Frasson, Francesca Chiarini, Daniele D’Avella, Benedetta Accordi, Laura Anselmi, Patrizia Barozzi, Fabio Forghieri, Mario Luppi, Alberto M. Martelli, Giuseppe...
During the 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma in Rotterdam (Netherlands), September 26-29, 2018 (http://cayanhl.pcrf-kids.org/ ), dr Federica Lovisa (Non Hodgkin Lymphoma – Molecular Diagnostics lab) was awarded...
During the 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma in Rotterdam (Netherlands), September 26-29, 2018 (http://cayanhl.pcrf-kids.org/ ), dr Federica Lovisa (Non Hodgkin Lymphoma – Molecular Diagnostics lab) was awarded...
Preclinical three‐dimensional colorectal cancer model: The next generation of in vitro drug efficacy evaluation Francesca Sensi, Edoardo D’Angelo, Sara D’Aronco, Roberto Molinaro, Marco Agostini J Cell Physiol. 2018;1–11
Trovare nuove terapie per una malattia pediatrica assai rara ma molto aggressiva: il tumore epatico. È questo l’ambizioso obiettivo del progetto europeo “Children’s Liver Tumour European Research Network” (ChiLTERN), incluso nel programma Horizon 2020-PHC-2015, di cui...
